Dashboard
Manage Tickers

CORCencora, Inc.

NYSE www.cencora.com


$ 222.12 $ 0.27 (0.12 %)    

Friday, 17-May-2024 15:59:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 451.63 $ -0.22 (-0.05 %)
DIA $ 399.76 $ 0.74 (0.19 %)
SPY $ 529.24 $ 0.76 (0.14 %)
TLT $ 91.40 $ -0.62 (-0.67 %)
GLD $ 223.63 $ 3.63 (1.65 %)
$ 222.12
$ 222.55
$ 0.00 x 0
$ 0.00 x 0
$ 221.24 - $ 222.55
$ 161.80 - $ 246.19
1,001,739
na
44.69B
$ 0.63
$ 24.12
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-01-2024 03-31-2024 10-Q
2 01-31-2024 12-31-2023 10-Q
3 11-21-2023 09-30-2023 10-K
4 08-02-2023 06-30-2023 10-Q
5 05-02-2023 03-31-2023 10-Q
6 02-01-2023 12-31-2022 10-Q
7 11-22-2022 09-30-2022 10-K
8 08-03-2022 06-30-2022 10-Q
9 05-04-2022 03-31-2022 10-Q
10 02-02-2022 12-31-2021 10-Q
11 11-23-2021 09-30-2021 10-K
12 08-04-2021 06-30-2021 10-Q
13 05-05-2021 03-31-2021 10-Q
14 02-04-2021 12-31-2020 10-Q
15 11-19-2020 09-30-2020 10-K
16 08-05-2020 06-30-2020 10-Q
17 05-07-2020 03-31-2020 10-Q
18 01-30-2020 12-31-2019 10-Q
19 11-19-2019 09-30-2019 10-K
20 08-01-2019 06-30-2019 10-Q
21 05-02-2019 03-31-2019 10-Q
22 01-31-2019 12-31-2018 10-Q
23 11-20-2018 09-30-2018 10-K
24 08-02-2018 06-30-2018 10-Q
25 05-02-2018 03-31-2018 10-Q
26 02-06-2018 12-31-2017 10-Q
27 11-21-2017 09-30-2017 10-K
28 08-03-2017 06-30-2017 10-Q
29 05-04-2017 03-31-2017 10-Q
30 01-31-2017 12-31-2016 10-Q
31 11-22-2016 09-30-2016 10-K
32 08-02-2016 06-30-2016 10-Q
33 05-05-2016 03-31-2016 10-Q
34 02-04-2016 12-31-2015 10-Q
35 11-24-2015 09-30-2015 10-K
36 08-06-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-Q
39 11-25-2014 09-30-2014 10-K
40 08-07-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

heres-how-much-1000-invested-in-cencora-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Cencora ...
05/16/2024 18:30:28

unveiling-4-analyst-insights-on-cencora
Unveiling 4 Analyst Insights On Cencora
05/02/2024 17:00:35

baird-maintains-outperform-on-cencora-raises-price-target-to-277
Baird Maintains Outperform on Cencora, Rai...
05/02/2024 10:48:10

Baird analyst David Rodgers maintains Cencora (NYSE:COR) with a Outperform and raises the price target from $275 to $277.

correction-cencora-q2-adj-eps-380-beats-369-estimate-sales-6841b-miss-7065b-estimate
CORRECTION: Cencora Q2 Adj. EPS $3.80 Beat...
05/01/2024 12:17:52

Cencora (NYSE:COR) reported quarterly earnings of $3.80 per share which beat the analyst consensus estimate of $3.69 by 2.98 pe...

cencora-sees-fy24-adj-eps-1330-1350-vs-1345-est
Cencora Sees FY24 Adj. EPS $13.30-$13.50 v...
05/01/2024 10:31:37

citigroup-maintains-buy-on-cencora-raises-price-target-to-280
Citigroup Maintains Buy on Cencora, Raises...
04/30/2024 14:22:10

Citigroup analyst Michael Rollins maintains Cencora (NYSE:COR) with a Buy and raises the price target from $265 to $280.

100-invested-in-this-stock-10-years-ago-would-be-worth-400-today
$100 Invested In This Stock 10 Years Ago W...
04/30/2024 14:00:30

if-you-invested-1000-in-this-stock-10-years-ago-you-would-have-3700-today
If You Invested $1000 In This Stock 10 Yea...
04/16/2024 16:30:37

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
04/09/2024 17:35:25

1000-invested-in-cencora-5-years-ago-would-be-worth-this-much-today
$1000 Invested In Cencora 5 Years Ago Woul...
03/29/2024 20:30:17

heres-how-much-100-invested-in-cencora-10-years-ago-would-be-worth-today
Here's How Much $100 Invested In Cencora 1...
03/13/2024 17:00:21

cencora-ceo-steven-h-collis-to-transition-to-executive-chair-coo-robert-p-mauch-to-become-president-and-ceo-both-appointments-effective-october-1-2024-reaffirms-fy24-guidance
Cencora CEO Steven H. Collis To Transition...
03/12/2024 12:46:47

CEO Steven H. Collis to Transition to Executive Chair; COO Robert P. Mauch to Become President and CEOBoth Appointments Effecti...

heres-how-much-you-would-have-made-owning-cencora-stock-in-the-last-5-years
Here's How Much You Would Have Made Owning...
02/28/2024 17:30:23

critical-insights-from-cencora-analyst-ratings-what-you-need-to-know
Critical Insights From Cencora Analyst Rat...
02/26/2024 18:00:37

leerink-partners-initiates-coverage-on-cencora-with-outperform-rating-announces-price-target-of-261
Leerink Partners Initiates Coverage On Cen...
02/26/2024 14:00:04

Leerink Partners analyst Michael Cherny initiates coverage on Cencora (NYSE:COR) with a Outperform rating and announces Pric...

us-federal-trade-commission-investigates-drug-shortages-amid-allegations-of-market-manipulation
US Federal Trade Commission Investigates D...
02/14/2024 18:25:53

FTC probes chemotherapy shortages, scrutinizing drug distributors and hospital groups. Root causes of drug shortages under scru...

heres-how-much-1000-invested-in-cencora-5-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Cencora ...
02/09/2024 18:30:19

Core News & Articles
Walgreens Boots Sells Cencora Shares For $...
02/08/2024 06:46:47

Walgreens Boots Alliance announces sale of shares of Cencora, Inc. for proceeds of $992 million Approximately $942 million s...

reported-earlier-cencora-prices-500m-5125-senior-notes-due-2034
Reported Earlier, Cencora Prices $500M 5.1...
02/06/2024 08:04:05

 The offering is being made pursuant to an effective shelf registration statement Cencora filed with the Securities and Exchang...

mizuho-maintains-neutral-on-cencora-raises-price-target-to-224-report-released-on-2-february-2024
Mizuho Maintains Neutral on Cencora, Raise...
02/05/2024 17:53:12

Mizuho analyst Omotayo Okusanya maintains Cencora (NYSE:COR) with a Neutral and raises the price target from $192 to $224.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION